LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma
Cancer Letters · 2024-07 · 595 · 217025
DOI: 10.1016/j.canlet.2024.217025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-07. Verfasst von Mingdi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, Jilin, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, AMP-Activated Protein Kinase Kinases, Cellular Senescence, Histones. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Program for Jilin University Science and Technology Innovative Research Team, Department of Science and Technology of Jilin Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite the confirmed role of LKB1 in suppressing lung cancer progression, its precise effect on cellular senescence is unknown. The aim of this research was to clarify the role and mechanism of LKB1 in restraining telomerase activity in lung adenocarcinoma. The results showed that LKB1 induced cellular senescence and apoptosis either in vitro or in vivo. Overexpression of LKB1 in LKB1-deficient A549 cells led to the inhibition of telomerase activity and the induction of telomere dysfunction by regulating telomerase reverse transcriptase (TERT) expression in terms of transcription. As a transcription factor, Sp1 mediated TERT inhibition after LKB1 overexpression. LKB1 induced lactate production and inhibited histone H4 (Lys8) and H4 (Lys16) lactylation, which further altered Sp1-related transcriptional activity. The telomerase inhibitor BIBR1532 was beneficial for achieving the optimum curative effect of traditional chemotherapeutic drugs accompanied by the glycolysis inhibitor 2DG. These data reveal a new mechanism by which LKB1 regulates telomerase activity through lactylation-dependent transcriptional inhibition, and therefore, provide new insights into the effects of LKB1-mediated senescence in lung adenocarcinoma. Our research has opened up new possibilities for the creation of new cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, Jilin, China.
- Department of Urology, the First Hospital of Jilin University, Changchun, 130021, Jilin, China.
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, Jilin, China. Electronic address: xiny@jlu.edu.cn.
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, Jilin, China. Electronic address: wangys@jlu.edu.cn.
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, Jilin, China. Electronic address: zhixiangxu@jlu.edu.cn.
Förderung
- Program for Jilin University Science and Technology Innovative Research Team
- Department of Science and Technology of Jilin Province
- National Natural Science Foundation of China
- Department of Finance of Jilin Province
Zitieren
APA
Liu, M., Gu, L., Zhang, Y., Li, Y., Zhang, L., Xin, Y., Wang, Y., & Xu, Z. X. (2024). LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma. Cancer Letters, 595, 217025. https://doi.org/10.1016/j.canlet.2024.217025
Vancouver
Liu M, Gu L, Zhang Y, Li Y, Zhang L, Xin Y, et al. LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma. Cancer Letters. 2024;595:217025. doi:10.1016/j.canlet.2024.217025
BibTeX
@article{Liu2024,
author = {Liu, Mingdi and Gu, Liting and Zhang, Yuning and Li, Yunkuo and Zhang, Lihong and Xin, Ying and Wang, Yishu and Xu, Zhi-Xiang},
title = {LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma},
journal = {Cancer Letters},
year = {2024},
volume = {595},
pages = {217025},
doi = {10.1016/j.canlet.2024.217025}
}
EUVIMED